Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleBRAIN

Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging

Giovanni B. Frisoni and Massimo Filippi
American Journal of Neuroradiology November 2005, 26 (10) 2488-2491;
Giovanni B. Frisoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Filippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. ↵
    Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 1994;35:S72–S89
  2. ↵
    Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28–37
    CrossRefPubMedWeb of Science
  3. ↵
    Rees J. Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 2003;16:643–650
    CrossRefPubMed
  4. ↵
    Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992;42:183–188
    Abstract/FREE Full Text
  5. ↵
    Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179–1183
    CrossRefPubMedWeb of Science
  6. ↵
    Smith AD. Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 2002;99:4135–4137
    FREE Full Text
  7. ↵
    Ashburner J, Csernansky JG, Davatzikos C, et al. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003;2:79–88
    CrossRefPubMedWeb of Science
  8. ↵
    Frisoni GB, Testa C, Zorzan A, et al. Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002;73:657–664
    Abstract/FREE Full Text
  9. ↵
    Frisoni GB, Padovani A, Wahlund L-O. The predementia diagnosis of Alzheimer’s disease. Alzheimer Dis Assoc Disord 2004;18:51–53
    CrossRefPubMed
  10. ↵
    Mandelkow EM, Stamer K, Vogel R, et al. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003;24:1079–1085
    CrossRefPubMedWeb of Science
  11. ↵
    van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–754
    CrossRefPubMedWeb of Science
  12. ↵
    Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400
    CrossRefPubMedWeb of Science
  13. ↵
    Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295–302
    CrossRefPubMedWeb of Science
  14. ↵
    Filippi M, Rovaris M, Inglese M, et al. Reduced brain tissue loss during randomised study of interferon β-1a in patients at presentation with syndromes suggestive of multiple sclerosis. Lancet 2004;364:1489–1496
    CrossRefPubMedWeb of Science
  15. ↵
    Filippi M, Bozzali M, Rovaris M, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003;126:433–437
    Abstract/FREE Full Text
  16. ↵
    Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing remitting multiple sclerosis. NeuroImage 2004;21:1825–1829
    CrossRefPubMedWeb of Science
  17. ↵
    Coles AJ, Wing MG, Molyneux P, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999;46:296–304
    CrossRefPubMedWeb of Science
  18. ↵
    Itagaki S, McGeer PL, Akiyama H, et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173–182
    CrossRefPubMedWeb of Science
  19. ↵
    Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461–467
    CrossRefPubMedWeb of Science
  20. ↵
    Golde TE. Inflammation takes on Alzheimer disease. Nat Med 2002;8:936–938
    CrossRefPubMed
  21. ↵
    Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer’s disease. Lancet Neurol 2002;1:279–284
    CrossRefPubMedWeb of Science
  22. ↵
    Filippi M, Rovaris M, Comi G, eds. Normal-appearing white and grey matter damage in multiple sclerosis. Springer-Verlag: Milan;2004
  23. ↵
    Iannucci G, Rovaris M, Giacomotti L, et al. Correlations between measures of multiple sclerosis pathology derived from T2, T1, magnetization transfer and diffusion tensor MR imaging. AJNR Am J Neuroradiol 2001;22:1462–1467
    Abstract/FREE Full Text
  24. ↵
    Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157–161
    Abstract/FREE Full Text
  25. ↵
    Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–395
    CrossRefPubMedWeb of Science
  26. ↵
    Rovaris M, Filippi M. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 1999;12:337–344
    CrossRefPubMedWeb of Science
  27. ↵
    Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;72:742–746
    Abstract/FREE Full Text
  28. Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750–757
    Abstract/FREE Full Text
  29. ↵
    Laakso MP, Hallikainen M, Hanninen T, et al. Diagnosis of Alzheimer’s disease: MRI of the hippocampus vs delayed recall. Neuropsychologia 2000;38:579–584
    CrossRefPubMedWeb of Science
  30. ↵
    Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer’s disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40–47
    CrossRefPubMedWeb of Science
  31. ↵
    Hanyu H, Asano T, Iwamoto T, et al. Magnetization transfer measurements of the hippocampus in patients with Alzheimer’s disease, vascular dementia, and other types of dementia. AJNR Am J Neuroradiol 2000;21:1235–1242
    Abstract/FREE Full Text
  32. ↵
    Mori E, Yoneda Y, Yamashita H, et al. Medial temporal structures relate to memory impairment in Alzheimer’s disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997;63:214–221
    Abstract/FREE Full Text
  33. ↵
    Robert PhH, Verhey FRJ, Byrne EJ, et al. Grouping for behavioural and psychological symptoms in dementia: clinical and biological aspects: consensus paper of the European Alzheimer’s Disease Consortium (EADC). Eur Psychiatry 2005 (in press)
  34. ↵
    Hanyu H, Asano T, Sakurai H, et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s disease. J Neurol Sci 1999;167:37–44
    CrossRefPubMedWeb of Science
  35. MacKay S, Meyerhoff DJ, Constans JM, et al. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167–74
    CrossRefPubMedWeb of Science
  36. ↵
    Yoshiura T, Mihara F, Ogomori K, et al. Diffusion tensor in posterior cingulate gyrus: correlation with cognitive decline in Alzheimer’s disease. Neuroreport 2002;13:2299–2302
    CrossRefPubMedWeb of Science
  37. ↵
    Bartzokis G, Sultzer D, Lu PH, et al. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease. Neurobiol Aging 2004;25:843–851
    CrossRefPubMedWeb of Science
  38. ↵
    Uchihara T, Kondo H, Akiyama H, Ikeda K. White matter amyloid in Alzheimer’s disease brain. Acta Neuropathol 1995;90:51–56
    PubMed
  39. ↵
    Filippi M. Magnetic resonance imaging findings predicting subsequent disease course in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neurol Sci 2001;22:S49–S51
  40. ↵
    Brex PA, Ciccarelli O, O’Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158–164
    CrossRefPubMedWeb of Science
  41. ↵
    McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–127
    CrossRefPubMedWeb of Science
  42. ↵
    Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397–1403
    Abstract/FREE Full Text
  43. ↵
    Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002;59:1729–1734
    CrossRefPubMedWeb of Science
  44. ↵
    Chetelat G, Desgranges B, De La Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 2003;60:1374–1377
    Abstract/FREE Full Text
  45. ↵
    Okamura N, Arai H, Maruyama M, et al. Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer’s disease. Am J Psychiatry 2002;159:474–476
    CrossRefPubMedWeb of Science
  46. ↵
    Citron M. Alzheimer’s disease: treatments in discovery and development. Nat Neurosci 2002;5:1055–1057
  47. ↵
    Filippi M, Rocca MA. Cortical reorganisation in patients with MS: using functional MRI techniques to study patients with MS. J Neurol Neurosurg Psychiatry 2004;75:1087–1089
    FREE Full Text
  48. ↵
    Saykin AJ, Flashman LA, Frutiger SA, et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer’s disease: patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377–392
    CrossRefPubMedWeb of Science
  49. Prvulovic D, Hubl D, Sack AT, et al. Functional imaging of visuospatial processing in Alzheimer’s disease. Neuroimage 2002;17:1403–1414
    CrossRefPubMedWeb of Science
  50. Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003;100:1454–1459
  51. ↵
    Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004;56:27–35
    CrossRefPubMedWeb of Science
  52. ↵
    De Vreese LP, Neri M, Fioravanti M, et al. Memory rehabilitation in Alzheimer’s disease: a review of progress. Int J Geriatr Psychiatry 2001;16:794–809
    CrossRefPubMedWeb of Science
  53. ↵
    Barkhof F, Filippi M, Miller DH, et al. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 1997;244:76–84
    CrossRefPubMedWeb of Science
  54. ↵
    Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147–1153
    Abstract/FREE Full Text
  55. ↵
    Mayeux R, Sano M. Treatment of Alzheimer’s disease. N Engl J Med 1999;341:1670–1679
    CrossRefPubMedWeb of Science
  56. ↵
    Growdon JH. Incorporating biomarkers into clinical drug trials in Alzheimer’s disease. J Alzheimers Dis 2001;3:287–292
    PubMed
  57. ↵
    Nordberg A. PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol 2004;3:519–527
    CrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 26 (10)
American Journal of Neuroradiology
Vol. 26, Issue 10
1 Nov 2005
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Giovanni B. Frisoni, Massimo Filippi
Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging
American Journal of Neuroradiology Nov 2005, 26 (10) 2488-2491;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging
Giovanni B. Frisoni, Massimo Filippi
American Journal of Neuroradiology Nov 2005, 26 (10) 2488-2491;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Understanding Disease Pathophysiology
    • Diffuse Structural Tissue Damage
    • White/Gray Matter Involvement
    • The Earliest Clinical Phase
    • Cortical Plasticity
    • Monitoring Treatment Efficacy
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study
  • Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire